SUBSCRIBE
SUBSCRIBE

Randomized, Controlled Multicenter Trial Demonstrates Safety and Clinical Benefit, Significant Reduction in Repeat Surgeries Enabled by Dune Medical Devices Ltd.'s MarginProbe(TM)

January 7, 2008 | 
1 min read
CAESAREA, Israel--(BUSINESS WIRE)--Dune Medical Devices announces significant new clinical developments surrounding the company’s novel breast cancer assessment probe, currently in investigational use.
Asia
MORE ON THIS TOPIC
3D rendering of a world map with area outlines. 3D illustration of a world map with country outlines.
China
Beyond China: Five other overseas destinations for biopharma dollars
September 9, 2026
 · 
8 min read
 · 
Tristan Manalac
Creative design. Desperate employee, office worker standing near question mark symbolizing business struggles, options. Choosing strategy for achieving goal. Concept of business, career development
Business
4 CDMOs to consider when outsourcing manufacturing
September 8, 2026
 · 
5 min read
 · 
Angela Gabriel
Rocket takeoff, gold light bulb on light blue background. Concept of start up launch and creativity. 3D rendering
Startups
10 life sciences startups selected for accelerator program
September 4, 2026
 · 
2 min read
 · 
Angela Gabriel
Gilded female hand holding a golden crown with dark chalkboard background. Royalty, succes and high quality concept.
Lung cancer
Summit, Akeso’s ivonescimab bests Merck’s Keytruda in China trial—again
September 3, 2026
 · 
2 min read
 · 
Annalee Armstrong